WCLC 2022 Conference Coverage


 

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Malignant Pleural Mesothelioma

29 views
September 7, 2022
0 Comments
Login to view comments. Click here to Login
Videos